These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hormesis as a biological hypothesis. Calabrese EJ; Baldwin LA Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):357-62. PubMed ID: 9539030 [TBL] [Abstract][Full Text] [Related]
3. Biphasic dose responses in biology, toxicology and medicine: accounting for their generalizability and quantitative features. Calabrese EJ Environ Pollut; 2013 Nov; 182():452-60. PubMed ID: 23992683 [TBL] [Abstract][Full Text] [Related]
4. Provocation of life functions at a unicellular eukaryote level by extremely low doses of mammalian hormones: Evidences of hormesis. Csaba G Acta Microbiol Immunol Hung; 2019 Dec; 67(1):1-5. PubMed ID: 31813260 [TBL] [Abstract][Full Text] [Related]
5. A swinging seesaw as a novel model mechanism for time-dependent hormesis under dose-dependent stimulatory and inhibitory effects: A case study on the toxicity of antibacterial chemicals to Aliivibrio fischeri. Sun H; Calabrese EJ; Zheng M; Wang D; Pan Y; Lin Z; Liu Y Chemosphere; 2018 Aug; 205():15-23. PubMed ID: 29679784 [TBL] [Abstract][Full Text] [Related]
6. Preconditioning is hormesis part II: How the conditioning dose mediates protection: Dose optimization within temporal and mechanistic frameworks. Calabrese EJ Pharmacol Res; 2016 Aug; 110():265-275. PubMed ID: 26748033 [TBL] [Abstract][Full Text] [Related]
7. Theodosius Dobzhansky's view on biology and evolution v.2.0: "Nothing in biology makes sense except in light of evolution and evolution's dependence on hormesis-mediated acquired resilience that optimizes biological performance and numerous diverse short and longer term protective strategies". Calabrese EJ; Agathokleous E Environ Res; 2020 Jul; 186():109559. PubMed ID: 32344211 [TBL] [Abstract][Full Text] [Related]
8. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone. Crain SM; Shen KF Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459 [TBL] [Abstract][Full Text] [Related]
9. Effects of the mammalian vasoconstrictor peptide, endothelin-1, on Tetrahymena pyriformis GL, and the immunocytological detection of endogenous endothelin-like activity. Köhidai L; Csaba G Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Jun; 111(2):311-6. PubMed ID: 8521250 [TBL] [Abstract][Full Text] [Related]
10. Exploring Possible Mechanisms of Hormesis and Homeopathy in the Light of Nanopharmacology and Ultra-High Dilutions. Ullman D Dose Response; 2021; 19(2):15593258211022983. PubMed ID: 34177397 [TBL] [Abstract][Full Text] [Related]
14. Formaldehyde: Another hormesis-inducing chemical. Agathokleous E; Calabrese EJ Environ Res; 2021 Aug; 199():111395. PubMed ID: 34048749 [TBL] [Abstract][Full Text] [Related]
15. Modeling non-monotonic dose-response relationships: model evaluation and hormetic quantities exploration. Zhu XW; Liu SS; Qin LT; Chen F; Liu HL Ecotoxicol Environ Saf; 2013 Mar; 89():130-6. PubMed ID: 23266374 [TBL] [Abstract][Full Text] [Related]
16. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling. Wang HY; Friedman E; Olmstead MC; Burns LH Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657 [TBL] [Abstract][Full Text] [Related]
17. Feedback phosphorylation of the yeast a-factor receptor requires activation of the downstream signaling pathway from G protein through mitogen-activated protein kinase. Feng Y; Davis NG Mol Cell Biol; 2000 Jan; 20(2):563-74. PubMed ID: 10611235 [TBL] [Abstract][Full Text] [Related]
18. Membrane-displayed peptide ligand activates the pheromone response pathway in Saccharomyces cerevisiae. Hara K; Ono T; Kuroda K; Ueda M J Biochem; 2012 May; 151(5):551-7. PubMed ID: 22406406 [TBL] [Abstract][Full Text] [Related]